Professional Documents
Culture Documents
APRIL-JUNE 2005
1. INTRODUCTION
2. INNOVATION SYSTEM
2.1 Indian Innovation System and Its Performance
A typical technological innovation system consists
of three broad segments which enables the journey of
an idea from human mind to market. The first phase
is called the Birth Phase, where commercially viable
idea gets converted into a workable prototype/process.
The next phase is called the Survival Phase wherein
up-scaling of the prototype to the pilot plant/pre* Shri Ashwani Gupta is Scientist-F and Dr. P.K. Dutta is Scientist-D in
Department of Scientific and Industrial Research, Ministry of Science
and Technology, Government of India. Article based on Paper
presented in the Asia-Pacific Forum on National Innovation Systems
(NIS) for High-Level Policy Makers: April 28-29, 2005, New Delhi.
EDITORIAL BOARD
Rajiv Yadav
India Trade Promotion Organisation
Ashwani Gupta
Department of Scientific & Industrial
Research
Nirupama Rao
Ministry of External Affairs
S.R. Rao
EXIM Bank
During last six years of its operation, the programme has been able to fulfill
the dreams of many innovative Indian citizens in their pursuit of becoming
technopreneurs. Since its inception, the Government of India under TePP
programme has given financial support to over 115 projects. Out of these, around
50 projects have been completed and around 25 projects have been
commercialized. The scheme has resulted in grant of domestic patents to more
than 10 innovators and US patent to 3 innovators, besides commercialization of
the processes/gadgets. Some of the successfully completed/commercialized
projects under TePP are tiltable bullock cart, innovative cotton stripper machine
(US patented), small 10 H.P. tractor, small sprayer (5 ltr. capacity), design cutting
machine, solid bio-mass fired furnace, alkali lignin from dry pine needles, diagonal
inverter for operation microscope, protein dialysis device (US patented), on-line
time domain moisture measurement, neem oil for non-healing wounds, novel
process for manufacturing heterocyclic chemicals, bus heating system, DC
MCBs, manufacturing of grape flakes, etc.
2.1.2 National Innovation Foundation (NIF)
The Government of India started National Innovation Foundation (NIF)
in March, 2000 by providing a corpus fund of Rs 200 million. NIF is an
autonomous body under the Department of Science and Technology,
Government of India. Its Chairman is Secretary, Department of Scientific
& Industrial Research (DSIR). NIF has its headquarters located at
Ahmedabad (India). NIF is developing a National Register of Green
Grassroots Technological Innovations and Traditional Knowledge. It also
seeks to develop a new model of poverty alleviation and employment
generation by helping convert grassroots innovations into enterprises.
2.1.3 NGO Mechanisms
EDITOR
Anil K. Kanungo
ISSN 0972-1460
SUBSCRIPTION RATES
Single Copy
: Rs 100 ; $5
Annual Subscription
: Rs 360 ; $18
BIRTH PHASE
IDEA SOURCE
GROWTH PHASE
Dependence on Support
Mechanisms Optional
Formal :
1. Public / Private funded
Universities/ Institutes
2. Public/ Private funded
R&D Laboratories/
Establishments
3. In-house R&D Centres
of Industry
4. SIROs
5. Start-up Companies
Idea
Proof of Concept
Prototype/ Working
Model
Commercial Product/
Process
Support Mechanisms
1. TDDP (Erstwhile
PATSER)
2. HGTP
3. PRDSF
4. Venture Capital Funding
* SIDBI
* ICICI- SPREAD
Idea
Dependence on
Support Mechanisms Required
Institutional
Funding
Informal:
1. Individual: Students, Teachers,
Artisans, Farmers,
etc.
2. NGOs
3. Unrecognized Industries
APRIL-JUNE 2005
SURVIVAL PHASE
1. STEPs
DST
2. TBIs
SIROs
NGOs
TePP
NIF
GIAN
SRISTI
SEVA
Institutional
Funding
RIN
CIIE
TePP
NMITLI
TDDP
HGTP
SIDBI
STEPs
TBIs
PRDSF
1.
2.
3.
4.
TDB
NMITLI
PRDSF
Venture Capital Funding
* SIDBI
* ICICI- SPREAD
2.1.10 Drug Development Programme and Pharmaceuticals Research and Development Support
Fund (PRDSF)
The Department of Science and Technology (DST)
launched a Drug Development Programme during 199495 for promoting collaborative R&D in drugs &
pharmaceuticals sector involving industries and
institutions. Fifty projects have been supported under the
Programme involving 22 institutions and R&D
establishments and 23 industries. These projects were about
development of new chemical entities, new vaccines, assay
systems, drug delivery systems and herbal drugs. These
projects have resulted in filing of 4 product patents and 12
process patents. The Programme has also led to setting
up of eight National Facilities for R&D.
The Government established a Pharmaceuticals
Research and Development Support Fund (PRDSF) of
APRIL-JUNE 2005
GENERAL
(viii) Lack of Synergy between Various Departments
and Agencies
(ix) Non-availability of Technical Expertise and
Testing & Trial Facilities at Affordable Rates
(x) No Organized System to Allow Sequential
Conversion of Projects from Idea to Prototype to
Commercial Stage
5. CONCLUSION
The Indian Innovation System can be viewed as a
system that is presently going through an evolution phase.
Indian innovation system is continuously adapting itself to
the newer ways of conducting R&D and funding the same.
It is keen to adopt select features of innovation systems in
other countries to improve its effectiveness. In this era of
globalization, Indian Innovation System would be keen to
participate in a global innovation system, wherein idea is
generated in one part of the world, prototype is developed
in another and it is commercialized in yet another part of
the world for global consumption.
There is an increased thrust on public-private
partnership models to nurture and support the entire
innovation chain in the country. Government is continuously
enhancing the S&T outlays over the five-year plan periods
and is allocating higher funds for supporting cutting-edge
R&D and innovative projects. For example, the Union Budget
2005 announced enhancement of corpus for Pharmaceuticals
Research and Development Support Fund. NGOs in tandem
with government are turning enthusiastic to trigger an
innovation movement in the country so as to enhance the
share of innovative products in countrys production and
exports and thereby help the country to attain a competitive
world ranking. Foreign venture capital institutions and angel
investors, e.g. Warburg Pincus, Temasek Holdings and
General Atlantic Partners are showing keen interest to
support the innovation activity in the country. That India
is a global platform for R&D has already been
demonstrated by the presence of more than hundred R&D
centres of MNCs in India. Now, India is aspiring to
establish itself as a manufacturing base for hi-tech
products and services. The growth of Indian Innovation
System in the coming years is expected to play a crucial
role in realization of this dream.
APRIL-JUNE 2005
JOINT VENTURES/
ACQUISITIONS/
SUBSIDIARIES
Wockhardt Sets Up Joint Ventures
in Mexico, South Africa
Drug company Wockhardt Ltd has formed two
business and marketing joint ventures in Mexico and
South Africa respectively, besides setting up a whollyowned subsidiary in Brazil. The new channels would be
for marketing Wockhardts insulin and other bio-pharma
and diabetes-related products in the global market. The
pharmaceutical market in Mexico is valued at $7 billion
and growing at 10 per cent.
TECHNOLOGY EXPORTS
KALEIDOSCOPE OF
INDIAS TECHNOLOGY EXPORT EFFORTS
10
The Act also, unlike the Ordinance, allows stronger pregrant opposition. Indian pharma companies challenging a
patent before it is granted have six months from the publishing
date of the patent and can be party to legal proceedings.
The third fear was availability of Indian drugs to poor
countries. The Ordinance had required the importing country
to issue a compulsory licence (an order that allows violation
of patent rights and general production for public interest).
Many poor countries could have missed out on Indian drugs
under this procedure. The Act allows exports even if the
importing country merely notifies its requirement.
More, Indian firms that are producing under compulsory
licence for the domestic market can also export their product
to poor nations. This will help the pharma sector retain a key
part of its business.
The Indian Patent Act 1970 did not allow patenting of
software but only copyright. The Patent Ordinance 2004
permitted patenting of embedded software but the Patents
Act 2005 has dropped protection to embedded software
provided by the Patents Amendment Act Ordinance 2004.
One line of belief in industry is that allowing patenting of
software embedded with hardware as also softwarehardware combination would have helped innovative SMEs
in the IT sector since there is an increasing awareness
among Indian ICT companies that IP is a valuable business
asset that drives business strategy to create revenue stream
that also fuel a nations economic growth. Other line of
belief is that if embedded software were protected, there
would be potential for conflict between hardware and
software producers. Software patents may inhibit
development of new hardware patents since a number of
hardware/software combinations might be possible in
developing different solutions.
INTERNATIONAL TECHNOLOGY
TRANSFER PROGRAMME
(ITTP)
11
FEEDBACK
NEW STUDIES
Centre for International Trade in Technology (CITT),
IIFT, has now taken up the following studies with the
support of DSIR, Ministry of S&T, Govt. of India.
Foreign R&D Centres in India
India is being projected as a hub for the
International R&D activities, and over one hundred
foreign R&D centres are reported to have been
established. The primary objective of the study is to
know about their experiences, intellectual property
generated, and contributions to the national R&D and
innovation systems. The study may also suggest
measures towards strengthening the present
mechanisms, if necessary.
12
Dear Readers,
Indian Institute of Foreign Trade (IIFT) in collaboration with
Department of Scientific & Industrial Research (DSIR) brings
out Quarterly Newsletter, Technology Exports.
The Newsletter aims to familiarise trade & industry with the
latest happenings and to bring out the policy analysis in the
field of technology exports.
We have received encouraging responses from Indian missions
abroad, embassies in India and trade & industry. Words of
praise, especially coming from various Indian missions have
been extremely fulfilling and inspiring for us.
While positive responses are highly encouraging, we believe
continued Readers Feedback will be the key factor not only
for improving the contents but also for maintaining sustained
interest.
Therefore, we at Technology Exports welcome Readers
valuable suggestions, inputs and constructive ideas. We would
appreciate receiving specific information such as lead articles,
exportable technological developments, achievements in
technology related exports, etc., for publication in the Newsletter.
Such information may be addressed to: Editor, Technology
Exports, Indian Institute of Foreign Trade, B-21 Qutab
Institutional Area, New Delhi-110 016.
E-mail: akanungo@iift.ac.in
Website: www.iift.edu
TECHNOLOGY EXPORTS